Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 11, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
- Aug 11, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Jul 28, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record33017 flagged findings
Reported transactions (Form 4)80since Jun 7, 2023 · and 1 other holding
Corporate events (8-K)14since Oct 19, 2021
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
What the company does
NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation.
Source: Wikidata (CC0 1.0) · copied on Sep 3, 2026 · may not reflect recent changes.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-12share offering or dilution eventrecentOpen filing ↗“…treatment at the seizure source. The Company began commercializing its products in the United States in 2014. At-the-Market…”
+1 more passage from the same document
- “…under an at-the-market, or ATM, equity program pursuant to a sales agreement with Leerink Partners LLC, or Leerink (formerly SVB…”
- 2026-05-12capital return (buybacks/dividends)recentOpen filing ↗“…In February 2025, the Company completed a follow-on offering of 7,475,000 shares of common stock, including 975,000 shares…”
+1 more passage from the same document
- “…of default and we may need to immediately repay the amounts due under the MidCap Term Loan. In June 2025, we entered into the MidCap…”
- 2026-05-12Department of Justice inquiryrecentOpen filing ↗“…we work. Additionally, our customers may be subject to additional federal and state privacy and security laws, rules, regulations and…”
+1 more passage from the same document
- “…any such actions can be detrimental to our reputation and brand and can otherwise be costly, time-consuming and may require…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 330)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Sep 4, 26SCHEDULE 13G/A ↗Passive stake · Mathew P. Arens · 12.3% · event on Aug 31, 26 · amendment
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · OrbiMed Advisors LLC · 4.4% · event on Jun 30, 26 · amendment
- Aug 11, 2610-Q ↗Quarterly report
- Aug 11, 268-K ↗Current report · Results
- Jul 28, 268-K ↗Current report · Communication to the market
- Jun 8, 268-K ↗Current report · Shareholder vote results
Insider transaction · 10 Form 4 filingsshow all 10hide
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 4, 26Form 4 ↗Insider transaction
- May 28, 26Form 4 ↗Insider transaction
- May 28, 26Form 4 ↗Insider transaction
- May 19, 26Form 4 ↗Insider transaction
330 filings on record, the oldest from Feb 25, 21.
Listing the 25 most recent filings of the 330 on record.
68
- Jun 24, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jun 4, 25Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Feb 14, 25Entered a material agreement8-K 1.01 ↗
- Jan 8, 25A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- Feb 7, 24A senior executive left or was appointed8-K 5.02 ↗
- Dec 4, 23Entered a material agreement8-K 1.01 ↗
4 senior executive changes2023show all 4hide
- Jul 19, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jun 28, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Apr 13, 23A senior executive left or was appointed8-K 5.02 ↗
- Jan 9, 23A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- Aug 11, 22Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Oct 19, 21A senior executive left or was appointed8-K 5.02 ↗
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- KCK LTD.17.7%Dec 31, 24SCHEDULE 13G/A ↗
- Mathew P. Arens12.3%Aug 31, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Polar Capital Holdings Plc9.1%Mar 31, 25SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- Soleus Capital Management, L.P.8.9%Sep 30, 25SCHEDULE 13G/A ↗9 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Morgan Stanley8.3%Dec 31, 24SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
show 2 more holdershide
- Kent Lake PR LLC4.9%Dec 31, 24SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- OrbiMed Advisors LLC4.4%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- Dec 15, 25Sell$399KMartha MorrellCHIEF MEDICAL OFFICER↗
Stock compensation, tax and giftsshow the 39 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Sep 24, 26Tax$5KMartha MorrellCHIEF MEDICAL OFFICER↗
- Sep 20, 26Tax$17KPatrick F. WilliamsChief Financial Officer↗
- Sep 3, 26Tax$19KJoel BeckerCHIEF EXECUTIVE OFFICER↗
- Aug 27, 26Tax$16KJoel BeckerCHIEF EXECUTIVE OFFICER↗
- Aug 27, 26Tax$5KMartha MorrellCHIEF MEDICAL OFFICER↗
- Jun 24, 26Tax$5KMartha MorrellCHIEF MEDICAL OFFICER↗
- Jun 19, 26Compensation$23KFrank M Fischer↗
- Jun 19, 26Compensation$12KUri Geiger↗
- Jun 19, 26Compensation$15KRakhi Kumar↗
- Jun 5, 26Compensationamount n/aFrank M Fischer↗
- Jun 5, 26Compensationamount n/aUri Geiger↗
- Jun 5, 26Compensationamount n/aLisa Andrade↗
- Jun 5, 26Compensationamount n/aR Scott Huennekens↗
- Jun 5, 26Compensationamount n/aRenee Ryan↗
- Jun 5, 26Compensationamount n/aRakhi Kumar↗
- Jun 3, 26Tax$20KJoel BeckerCHIEF EXECUTIVE OFFICER↗
- May 27, 26Tax$19KJoel BeckerCHIEF EXECUTIVE OFFICER↗
- May 27, 26Tax$6KMartha MorrellCHIEF MEDICAL OFFICER↗
- May 15, 26Compensationamount n/aJoel BeckerCHIEF EXECUTIVE OFFICER↗
- May 15, 26Compensationamount n/aPatrick F. WilliamsChief Financial Officer↗
- May 15, 26Compensationamount n/aMartha MorrellCHIEF MEDICAL OFFICER↗
- Mar 24, 26Tax$18KMartha MorrellCHIEF MEDICAL OFFICER↗
- Mar 20, 26Compensation$24KFrank M Fischer↗
- Mar 20, 26Compensation$15KRakhi Kumar↗
- Mar 20, 26Compensation$11KJOSEPH LACOB↗
- Mar 20, 26Compensation$12KUri Geiger↗
- Mar 3, 26Tax$69KJoel BeckerCHIEF EXECUTIVE OFFICER↗
- Mar 3, 26Tax$19KMartha MorrellCHIEF MEDICAL OFFICER↗
- Feb 27, 26Tax$16KJoel BeckerCHIEF EXECUTIVE OFFICER↗
- Feb 27, 26Tax$5KMartha MorrellCHIEF MEDICAL OFFICER↗
- Feb 20, 26Tax$49KMartha MorrellCHIEF MEDICAL OFFICER↗
- Dec 19, 25Compensation$11KJOSEPH LACOB↗
- Dec 19, 25Compensation$24KFrank M Fischer↗
- Dec 19, 25Compensation$12KUri Geiger↗
- Dec 19, 25Compensation$15KRakhi Kumar↗
- Dec 3, 25Tax$22KMartha MorrellCHIEF MEDICAL OFFICER↗
- Nov 27, 25Tax$19KJoel BeckerCHIEF EXECUTIVE OFFICER↗
- Nov 27, 25Tax$6KMartha MorrellCHIEF MEDICAL OFFICER↗
- Nov 20, 25Tax$41KMartha MorrellCHIEF MEDICAL OFFICER↗
The full record holds 231 transactions and goes back to Apr 22, 22.
Its sector and its market
NeuroPace Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From NeuroPace Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow NeuroPace Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 330 documents on file, from Feb 25, 2021 to Sep 25, 2026.
- Company description
- Wikidata, read on Sep 3, 2026.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.